Braskem/$BAK
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Braskem
Braskem SA is engaged in the manufacture, sale, import and export of chemicals, petrochemicals and fuels, as well as the production, supply and sale of utilities such as steam, water, compressed air and industrial gases. It also provides industrial services and is engaged in the production, supply and sale of electric energy and gas for its own use and use by other companies. Its segments include Brazil, USA and Europe; and Mexico. The Brazil segments delivered the majority of the revenue from the production and sale of chemicals; the supply of electricity and other inputs produced in these complexes to second-generation producers located in the petrochemical complexes; and the production and sale of PE, including the production of green PE made from renewable resources, and of PP.
- Ticker
- $BAK
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- 8,233
- Headquarters
- São Paulo, Brazil
- Website
- www.braskem.com.br
Braskem Metrics
BasicAdvanced
$473M
-
-$1.26
0.67
-
Price and volume
Market cap
$473M
Beta
0.67
52-week high
$5.40
52-week low
$0.74
Average daily volume
3M
Financial strength
Current ratio
0.771
Quick ratio
0.416
Long term debt to equity
-3.524
Total debt to equity
-5.219
Interest coverage (TTM)
0.89%
Profitability
EBITDA (TTM)
1,515.535
Gross margin (TTM)
11.52%
Net profit margin (TTM)
-7.85%
Operating margin (TTM)
6.70%
Effective tax rate (TTM)
579.68%
Revenue per employee (TTM)
$1,558,210
Management effectiveness
Return on assets (TTM)
3.47%
Return on equity (TTM)
81.17%
Valuation
Price to revenue (TTM)
0.068
Price to book
-0.21
Price to tangible book (TTM)
-0.17
Price to free cash flow (TTM)
-0.543
Free cash flow yield (TTM)
-184.19%
Free cash flow per share (TTM)
-2.008
Growth
Revenue change (TTM)
-9.17%
Earnings per share change (TTM)
-4.63%
3-year revenue growth (CAGR)
-4.70%
10-year revenue growth (CAGR)
3.78%
3-year earnings per share growth (CAGR)
17.63%
10-year earnings per share growth (CAGR)
6.69%
What the Analysts think about Braskem
Analyst ratings (Buy, Hold, Sell) for Braskem stock.
Analyst projections of the future price of Braskem stock.
Bulls say / Bears say
Braskem’s recurring EBITDA rebounded to US$1.04bn in the second quarter from US$192m in the first, as wider petrochemical spreads showed how strongly earnings can respond when margins improve. (Braskem)
Creditors and shareholders were reported to be nearing a deal to restructure about US$11bn of debt, which could avert bankruptcy and give the business a path to a more workable balance sheet. Significant differences remain, so the agreement is not assured. (Bloomberg)
IG4 and Petrobras became Braskem’s co-controllers in June, ending Novonor’s control after several failed efforts to sell its stake. A more settled ownership structure could support a turnaround, though execution is still unproven. (Reuters)
Braskem Idesa remains operationally constrained: Moody’s cites subdued Mexican operations and declining ethane supplies from Pemex. This limits a key business segment while the group is already under financial strain. (Moody's)
Data summarised monthly by Lightyear AI. Last updated on 27 Oct 2026.
Braskem Financial Performance
Revenues and expenses
Braskem Earnings Performance
Company profitability
Upcoming events
No upcoming events
Braskem News
AllArticlesVideos
Funds containing Braskem
Fund name | Fund size | $BAK weighting |
|---|---|---|
SPDR MSCI Emerging Markets Small Cap£EMSM | $647M | 0.01% |
SPDR MSCI All Country World IM€SPYI | $7.7B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.